NCT06576128

Brief Summary

Sensory innervation of the femoral region which is the entry point for endovascular cardiac interventions such as coronary angiography,cardiac catheterization and percutaneous coronary intervention is complex.It is thought that the ilioinguinal and iliohypogastric nerves contribute mostly.With transversus abdominis plane block(TAPB),it is planned to provide analgesia by creating a block in these nerve branches that contribute to the sensory innervation of the intervention area.In addition;it was aimed to investigate patient's and physician's satisfaction during the procedure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

September 10, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

September 10, 2025

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

August 26, 2024

Last Update Submit

September 3, 2025

Conditions

Keywords

ultrasonographyanesthesiologytransversus abdominis plane blockPercutaneous Coronary InterventionCardiac Catheterizationanalgesia

Outcome Measures

Primary Outcomes (2)

  • measuring the analgesic efficacy of TAPB

    The pain will be assessed by the Numeric Rating Scale-11(NRS -11) to measure the analgesic efficacy of TAPB. Minimum pain score is point zero, maximum pain score is ten points.Minimum pain scores (NRS is less than 4 points) will have positive outcomes.

    4 months

  • For patient and physician satisfaction;5-point Likert scale will be used. Minimum satisfaction score is one point, maksimum satisfaction score is five points.Higher scores have positive outcomes.

    One point represents strongly unsatisfied and 5 points represent strongly satisfied.

    4 months

Study Arms (2)

control group

SHAM COMPARATOR

only local anesthesia will be applied to surgical field as a part of the routine procedure.

Procedure: parenteral local anesthesia

block group

ACTIVE COMPARATOR

local anesthesia will be applied to surgical field as a part of the routine procedure and additionally transversus abdominisl plane block will be applied.

Device: ultrasound

Interventions

In additional to local anesthesia, 10 ml lidocaine (2%) (Lidon, Onfarma, Turkey ), TAPB will be performed under ultrasound imaging..

block group

As routine procedure; the cardiologist will palpate the right or left femoral artery under sterile conditions and apply approximately 10 ml lidocaine (2%) to this area as local anesthesia (Lidon, Onfarma, Turkey ). Then, a puncture will be made on the anterior wall of the femoral artery with an 18 G needle . Approximately 3-4 mm skin incision will be made with the number 11 scalpel tip and the Seldinger technique will be continued. 6F femoral sheath to be placed, cardiac The catheterization process will begin.

control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient is over 18 years of age
  • Coronary angiography, cardiac catheterization and percutaneous coronary intervention will be applied to the patient,
  • The above-mentioned procedures will be taken under elective conditions,
  • Providing an optimal image when imaging the patient with ultrasound,
  • INR\< 1.5
  • If the patient gives consent, S/he will be included in the study.

You may not qualify if:

  • Patients under 18 years of age,
  • Patients treated under emergency conditions,
  • morbid obesity (BMI\>35 kg/m2),
  • pregnant women,
  • New York Heart Association (NYHA) stage 4 patients with advanced decompensated heart failure,
  • Patients with symptoms such as redness, temperature increase, infection, hematoma in the application area before the procedure,
  • Patients with a history of allergy to local anesthetics,
  • Patients who cannot be communicated,
  • Those with severe psychosis or progressive neurological deficits and muscle disease,
  • Patients who do not consent to the application will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University- Cerrahpasa

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

AgnosiaPatient Satisfaction

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Kerem Erkalp

    Proffessor

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
proffessor

Study Record Dates

First Submitted

August 26, 2024

First Posted

August 28, 2024

Study Start

September 10, 2024

Primary Completion

October 15, 2025

Study Completion

December 15, 2025

Last Updated

September 10, 2025

Record last verified: 2025-05

Locations